Velcade (Bortezomib)


VELCADE (BORTEZOMIB) is an antineoplastic agent the first in a new class of drugs called proteasome inhibitors, an example of target chemotherapy. BORTEZOMIB mechanism of action is by inhibiting enzyme complexes called proteasomes. Both normal cells and cancer cells contain proteasomes that break down damaged proteins into smaller components. Inhibition of proteasomes causes accumulation of proteins in cancer cells. This accumulation may cause cancerous cells to stop growing, dividing, and multiplying, causing them to die. The goal of VELCADE (BORTEZOMIB) treatment is to target rapidly dividing cancer cells and stop them from multiplying. Cancer cells appear to be more sensitive to these effects than normal cells, so that cancer cells die while normal cells can recover.Velcade

VELCADE manufacturer is Millennium pharmaceuticals a subsidiary of Takeda pharmaceutical company. VELCADE (BORTEZOMIB) has an FDA approval for the treatment of multiple myeloma and relapsed mantle cell lymphoma. It was approved for the treatment of relapsed/refractory myeloma in May 2003. Frontline setting approval was only until 2008.

BORTEZOMIB is also an important treatment option for patients who have become refractory to and or relapsed on previous therapies.

It is a modified dipeptidyl boronic acid. The product is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its hydrolysis product, the monomeric boronic acid. The drug substance exists in its cyclic anhydride form as a trimeric boroxine. Bortezomib solubility, as the monomeric boronic acid, in water is 3.3 to 3.8 mg/mL.

The BORTEZOMIB structure; C19H25BN4O4Velcade 2VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol. It is also not used in pregnant women because it is a pregnancy category D drug thus can harm the unborn child.

WARNING: It can cause serious and painful peripheral neuropathy.

VELCADE DOSAGE forms and strengths: Each single dose vial of VELCADE contains 3.5 mg of bortezomib as a sterile lyophilized powder.


This prescription is provided by a doctor and is generally not available at a pharmacy. This drug is administered by your healthcare practitioner (HCP), which usually means:

  • You cannot fill this prescription in a regular pharmacy. Your doctor, hospital, or clinic will provide this medication.
  • It may be covered by your insurance company

VELCADE 3.5 mg is averagely $4500 per cycle in the USA.

For bulk orders Buy VELCADE online to spend less and save more At we offer VELCADE at the cheapest prices. We deliver worldwide so wherever you are just log into our site and order yours today and save a lot

On all your orders Indian and European pharmacies will dispatch the medicine you order from

How to order

All you need is a phone, tablet or a computer and an internet connection. Find our site, search for the drug, check availability (in stock or out of stock) then click buy. You will be prompted to sign up so as we get your email and postal addresses for delivery purposes. Choose a payment option then wait for your order to arrive.

Why buy from us?

We are a recognized online drugs supplier that has maintained a wide network across the world since its creation. Our clients can now conveniently buy VELCADE (BORTEZOMIB) at cheaper prices in the USA, UK, Russia, China, Japan, Europe, Africa, and other parts of the world.

Our drug products are the world’s cheapest, with same high quality of Brand or Generic.

We provide fast and express deliveries so you get your ordered medication within the time limit.

We have a safe and secure payment process so you can rest assured that no one will ever gain access to your credit and debit cards.

We also do bulk exports to most destinations in the world and so if you are a bulk importer then have no worries, we’ve got you. All you need is a valid import licence and you are good to go.

We also supply in bulk Brand equivalent generic cancer drugs to NGOs

To facilitate easier transactions ensure to register with all your current details including postal and email addresses. Details of your products including product number will be emailed to you. These assist us in keeping track of your orders and making sure they get to you.

Need wholesale? Or maybe retail order VELCADE (BORTEZOMIB) today at the world’s cheapest prices at

Shipping information

Bulk orders

Here we work to ensure that you receive your VELCADE (BORTEZOMIB) drug order at the agreed upon time. We keep you updated on your order from the moment of order till day or time of pickup. Shipping periods will vary depending on where you are.

Make sure you give up to date addresses (postal and email) so as to facilitate faster deliveries.

Please note that our shipping excludes any custom fees, taxes and duty that may arise as a result of shipping your package.

Non-Bulk orders

Orders must be accompanied by a doctor’s prescription. We do not accept final customer orders without a doctor’s prescription. VELCADE (BORTEZOMIB) is not sold over the counter anywhere.

Patients with prescriptions can order directly online through our website, it is simple and not to mention fairly cheap as compared to other drug pharmacies. After ordering, you can sit back and wait for your medication to come through

On all your orders Indian and European pharmacies will dispatch the medicine you order from

Refund Policy

You may cancel your order anytime within seven working days, from after you receive the drug products, we will refund the price of the products in full on receiving them back as they were.

If your consignment does not arrive within the stipulated dates or gets lost somehow, we will ship to you another consignment or a full refund as per your request.

If refund is payable it will be processed as soon as possible. All products returned must be in same condition you received them and in original containers.

You have legal obligation to take reasonable care of goods while in your possession. Make sure to acquaint yourself with local laws on refund and goods handling.


All our brand products are 100% original.

Buy cheap VELCADE (BORTEZOMIB) online from, the world’s cheapest supplier of cancer drugs.

Our generic products are of top quality, each has clear information about manufacturer, date of manufacture and serial numbers to confirm manufacturers.

Our products are clearly labelled so if it is a generic or brand you will know exactly what you are ordering.

VELCADE (BORTEZOMIB) Product Description

BORTEZOMIB is a chemotherapy drug in the pharmacologic class of proteasome inhibitors available for intravenous injection or subcutaneous use only. Each single dose vial of VELCADE contains 3.5 mg of bortezomib as a sterile lyophilized white to off-white powder. Inactive ingredient: 35 mg mannitol, USP.

VELCADE is the brand name while BORTEZOMIB is the generic name.

BORTEZOMIB is indicated for treatment of patients with multiple myeloma who have received and treatment of patients with mantle cell lymphoma.

It is used in combination with drugs like cyclophosphamide,rituximab, doxorubicin and oral prednisone.

VELCADE is not an over the counter drug and one has to have a valid doctor’s prescription before acquiring the drug.


The recommended starting dose of VELCADE is 1.3 mg/m2. VELCADE (BORTEZOMIB)may be administered intravenously at a concentration of 1 mg/mL, or subcutaneously at a concentration of 2.5 mg/ml. Velcade injection is administered as a 3 to 5 second bolus. VELCADE is for intravenous or subcutaneous use only. It should not be administered by any other route.

VELCADE dosing in previously untreated Multiple Myeloma (ADULT)

  • VELCADE is administered in combination with oral melphalan and oral prednisone for nine 6-week treatment cycles. BORTEZOMIB dose is 1.3 mg/m2, Melphalan at 9 mg/m2 and Prednisone at 60 mg/m2
  • At least 72 hours should elapse between consecutive doses of VELCADE.

BORTEZOMIB dosing in previously untreated Mantle cell lymphoma (ADULT)

  • VELCADE (1.3 mg/m2) is administered intravenously in combination with intravenous rituximab, cyclophosphamide, doxorubicin and oral prednisone (VcR-CAP) for six 3-week treatment cycles. VELCADE is administered first followed by rituximab. VELCADE (BORTEZOMIB) is administered twice weekly for two weeks (Days 1, 4, 8, and 11) followed by a 10-day rest period on Days 12-21. For patients with a response first documented at cycle 6, two additional VcR-CAP cycles are recommended. At least 72 hours should elapse between consecutive doses of VELCADE.
  • Rituximab dose at 375 mg/m2, Cyclophosphamide dose at 750 mg/m2, doxorubicin dose at 50 mg/m2, Oral prednisone at 50 mg/m2.

VELCADE dosing for Relapsed Multiple Myeloma and Relapsed Mantle Cell Lymphoma (ADULT)

  • VELCADE (1.3 mg/m2/dose) is administered twice weekly for 2 weeks (Days 1, 4, 8, and 11) followed by a 10-day rest period (Days 12-21). For extended therapy of more than 8 cycles, VELCADE may be administered on the standard schedule or, for relapsed multiple myeloma, on a maintenance schedule of once weekly for 4 weeks (Days 1, 8, 15, and 22) followed by a 13-day rest period (Days 23 to 35). At least 72 hours should elapse between consecutive
  • BORTEZOMIB therapy should be withheld at the onset of any Grade 3 non-hematological or Grade 4 hematological toxicities excluding neuropathy

Patients with moderate or severe hepatic impairment should be started on BORTEZOMIB at a reduced dose of 0.7 mg/m2 per injection during the first cycle, and a subsequent dose escalation to 1.0 mg/m2 or further dose reduction to 0.5 mg/m2 may be considered based on patient tolerance

Patients with mild hepatic impairment do not need a starting dose modification and should be treated as per the recommended dose.

Efficacy and safety in children not established.


  • VELCADE is contraindicated for intrathecal administration. Fatal events have occurred with intrathecal administration of VELCADE.
  • VELCADE is contraindicated in patients with hypersensitivity (allergic reactions) to bortezomib, boron, or mannitol. Reactions have included anaphylactic reactions


In BORTEZOMIB subcutaneous administration, sites for each injection (thigh or abdomen) should be rotated. New injections should be given at least one inch from an old site and never into areas where the site is tender, bruised, or erythematous.

If local injection site reactions occur following VELCADE administration subcutaneously, a less concentrated VELCADE solution (1 mg/mL instead of 2.5 mg/mL) may be administered subcutaneously. Intravenous administration should be considered.

VELCADE treatment causes a peripheral neuropathy that is predominantly sensory; however, cases of severe sensory and motor peripheral neuropathy have been reported. Patients with pre-existing symptoms (numbness, pain or a burning feeling in the feet or hands) and/or signs of peripheral neuropathy may experience worsening peripheral neuropathy (including ≥ Grade 3) during treatment with VELCADE (BORTEZOMIB).

Caution should be used when treating patients with a history of syncope, patients receiving medications known to be associated with hypotension, and patients who are dehydrated.Patients with risk factors for, or existing heart disease should be closely monitored.


Store in a cool and dry place at room temperature

Proper disposal of expired medicines BORTEZOMIB is an antineoplastic agent therefore great care has to be taken.


You should not use Velcade if you are allergic to bortezomib, mannitol, or boron.

Make sure you are not pregnant because VELCADE can harm your unborn child.

Inform you doctor of any medical conditions you have, diabetes liver problems heart problems blood pressure problems etc

Inform your doctor of any other medication (prescription or non prescription) that you are taking.


It is important to receive each scheduled VELCADE dosage as directed. If you miss a dose make sure you receive it as soon as possible but not close to your next dose if so contact your doctor to establish a way forward.


Most common VELCADE side effects (incidence ≥ 20%) include nausea, diarrhea, thrombocytopenia, neutropenia, peripheral neuropathy, fatigue, neuralgia, anemia, leukopenia, constipation, vomiting, lymphopenia, rash, pyrexia, and anorexia

The following are uncommon but may occur;

  • Difficulty sleeping (Insomnia)
  • Joint pains, arthralgia, myalgias
  • Swelling of the face, hands, feet or legs (edema).
  • Low white blood cell count. (This can put you at increased risk for infection.)
  • Shortness of breath
  • Dizziness
  • Rash (see skin reactions)
  • Dehydration
  • Upper respiratory tract infection
  • Cough
  • Bone pain
  • Anxiety
  • Muscle cramps
  • Heartburn
  • Abdominal pain
  • Low blood pressure
  • Itching
  • Blurring of vision
  • Blood test abnormalities

Hair loss – BORTEZOMIB can cause hair loss in some patients.


  • Patients with diabetes may require close monitoring while on VELCADE therapy and adjustment of their antidiabetic medication.
  • Regular monitoring of certain blood profiles will be done by your doctor to check for reactions and adverse effects. Blood profiles including; Complete blood count (CBC), chemistry profile; Glucose, BUN (Blood Urea Nitrogen), Creatinine protein and calcium
  • Patients should be monitored for symptoms of neuropathy such as such as a burning sensation, hyperesthesia, hypoesthesia, paresthesia, discomfort, neuropathic pain or weakness


BORTEZOMIB is metabolized by Cytochrome p450 3A4, 2C19 and 1A2. It is therefore prone to drug interactions with medicines that affect directly or indirectly these enzymes.

This may change how VELCADE works or increase your risk of side effects.

Keep a list of all the products you use (including prescription/non-prescription drugs, supplements, vitamins and herbal products) and share it with your doctor.

Some medications will affect the rate of elimination of VELCADE examples;

Azole antifungals (eg ketoconazole), macrolide antibiotics (such as erythromycin), rifamycins (such as rifabutin), St. John’s wort, drugs used to treat seizures (such as carbamazepine, phenytoin)

Other medications can interact directly with BORTEZOMIB and include; Antihypertensive drugs, oral anti-diabetics; sulfonyl ureas, other drugs that cause peripheral neuropathy; amiodarone, isoniazid, nitrofurantoin, certain anti-virals such as acyclovir, ritonavir, zidovudine.

St. John’s Wort (Hypericum perforatum) may decrease bortezomib exposure unpredictably and should be avoided.

It is very important that you let your doctor know of any other medications you are taking.

For all your wholesale or retail VELCADE (BORTEZOMID) order and at the lowest cost, contact us through and get your order shipped to you anywhere around the world.

Frequently asked Questions

What are the most common side effects of VELCADE?

Most common VELCADE side effects (incidence ≥ 20%) include nausea, diarrhea, thrombocytopenia, neutropenia, peripheral neuropathy, fatigue, neuralgia, anemia, leukopenia, constipation, vomiting, lymphopenia, rash, pyrexia, and anorexia

Does VELCADE interact with other drugs?

It does interact with several other medications so make sure to tell your doctor of any other medication you are taking.

What happens when I miss a dose of BORTEZOMIB?

It is important that you receive each scheduled VELCADE dosage as directed. If you miss a dose make sure you receive it as soon as possible but not close to your next dose if so contact your doctor to establish a way forward.

When will my order ship?

Orders are shipped Monday through Friday, excluding legal holidays.

How do I track my order to know where it is in transit?

Every time you place an order, you’ll receive an email from us notifying you of its status.

Customer Reviews

“I received Valcade for multi-myeloma for four and a half months. I was scheduled for another 4 months but reached a level of remission that did not require any more chemo. Pleased with the results.”

“Velcade is working well for, the side effects can be intense sometimes but that’s a small price to pay.”

“The pain from neuropathy in the feet, ankles and legs is excruciating. It is so bad that I cannot be on my feet for more that 2 min at a time. The worst part is, the pain just doesn’t go away.”

“The injection is relatively painless and I have had little if any side effects aside from thirst and hunger.”

“I have loss muscle mass since I started BORTEZOMIB, and I have tingling in my feet. I also don’t have very much energy. Walking can also be difficult.”

“Apart from the severe side effects of Velcade Iam content with how it is working for me.”

“You have to be satisfied with being in remission, but the neuropathy in my feet really makes me question whether or not I should have gone the transplant route.”